No photo of Joel Charrow

View Scopus Profile

Joel Charrow

  • 6768 Citations
1978 …2050

Research output per year

If you made any changes in Pure these will be visible here soon.

Grants

Active

Natural history study for pediatric patients with early onset of either GM1 gangliosidosis, GM2 gangliosidoses, or Gaucher disease type 2

Charrow, J.

Idorsia Pharmaceutical Ltd

11/6/19 → 8/31/50

Project: Research project

A Phase 1/2 Study of ARQ 092 (Miransertib) in Subjects with PIK3CA-related Overgrowth Spectrum and Proteus Syndrome

Charrow, J.

ArQule, Inc.

4/25/19 → 8/31/50

Project: Research project

BMN 111-302: A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondroplasia

Charrow, J.

BioMarin Pharmaceutical Inc.

12/18/18 → 8/31/50

Project: Research project

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children with Achondroplasia, Age 0 to < 60 Months (111-206)

Charrow, J.

BioMarin Pharmaceutical Inc.

9/26/18 → 9/25/21

Project: Research project

Lysosomal Storage Disease Training Program for Genetic Counselors

Charrow, J.

Genzyme Corporation

9/1/18 → 7/31/21

Project: Research project

Lysosomal Storage Disease Training Program for Genetic Counselors

Charrow, J.

Genzyme Corporation

9/1/18 → 7/31/21

Project: Research project

Lysosomal Storage Disease Training Program for Genetic Counselors

Charrow, J.

Genzyme Corporation

9/1/18 → 7/31/21

Project: Research project

Protalix PB-102-F20: A Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 compared to Agalsidase Beta on Renal Function in Patients with Fabry Disease Previously Treated With Agalsidase Beta

Burton, B. K. & Charrow, J.

Protalix Ltd.

5/16/18 → 5/15/21

Project: Research project

EFC-14028: A Phase 3 Randomized, Multicenter, Multinational, Double-Blinded Study Comparing the Efficacy and Safety of Repeated Biweekly Infusions of neoGAA (GZ402666) and Alglucosidase Alfa

Burton, B. K. & Charrow, J.

Sanofi US Services Inc.

12/11/17 → 12/31/21

Project: Research project

Shire SHP-GCB-402: An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment with Velaglucerase alfa on Bone-related Pathology in Treatment-naive Patients with Type 1 Gaucher Disease

Burton, B. K. & Charrow, J.

Shire Human Genetic Therapies, Inc.

6/30/17 → 6/30/20

Project: Research project

A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of BMN 111 in Children with Achondroplasia

Burton, B. K. & Charrow, J.

BioMarin Pharmaceutical Inc.

1/21/16 → 9/30/24

Project: Research project

SHP-ELA-401: A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age

Burton, B. K. & Charrow, J.

Shire Human Genetic Therapies, Inc.

4/13/15 → 6/4/21

Project: Research project

MARS: Morquio A Registry

Burton, B. K. & Charrow, J.

BioMarin Pharmaceutical Inc.

12/15/14 → 12/16/24

Project: Research project

HPN-100-014: Long-Term Registry of Patients With Urea Cycle Disorders (UCDs) - THRIVE

Burton, B. K. & Charrow, J.

Hyperion Therapeutics, Inc.

12/11/13 → 12/11/23

Project: Research project

Clinical Genetic & Nutritional Counseling Services for Newborn Screening

Charrow, J.

Illinois Department of Public Health

7/1/13 → 6/30/20

Project: Research project

Clinical Genetic & Nutritional Counseling Services for Newborn Screening

Charrow, J.

Illinois Department of Public Health

7/1/13 → 6/30/20

Project: Research project

Clinical Genetic & Nutritional Counseling Services for Newborn Screening

Charrow, J.

Illinois Department of Public Health

7/1/13 → 6/30/20

Project: Research project

Clinical Genetic & Nutritional Counseling Services for Newborn Screening

Charrow, J.

Illinois Department of Public Health

7/1/13 → 6/30/20

Project: Research project

Clinical Genetic & Nutritional Counseling Services for Newborn Screening

Charrow, J.

Illinois Department of Public Health

7/1/13 → 6/30/20

Project: Research project

Clinical Genetic & Nutritional Counseling Services for Newborn Screening

Charrow, J.

Illinois Department of Public Health

7/1/13 → 6/30/20

Project: Research project

Clinical Genetic & Nutritional Counseling Services for Newborn Screening

Charrow, J.

Illinois Department of Public Health

7/1/13 → 6/30/20

Project: Research project

Finished

BMN 111-301: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN 111 in Children with Achondroplasia

Burton, B. K. & Charrow, J.

BioMarin Pharmaceutical Inc.

10/1/17 → 12/31/19

Project: Research project

AGT-182-101: A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human Iduronate 2-Sulfatase (IDS) Fusion Protein, AGT-182 in Adult Patients with Mucopolysaccharidosis II (MPS II, Hunter Syn

Alden, T. D., Burton, B. K., Charrow, J. & Epstein, L. G.

ArmaGen, Inc.

10/1/15 → 10/1/16

Project: Research project

AGT-181-102: A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human alpha-L-iduronidase (HIRMAb-IDUA) Fusion Protein, AGT-181 in Adult Patients with Mucopolysaccharidosis I (MPS I)

Alden, T. D., Burton, B. K. & Charrow, J.

ArmaGen, Inc.

9/24/15 → 12/31/16

Project: Research project

SHP-609-302: An Open Label Extension of Study HGT-HIT-094 Evaluating Long Term Safety and Clinical Outcomes of Intrathecal Idursulfase Administered in Conjunction with Elaprase® in Patients with Hunter Syndrome and Cognitive Im

Alden, T. D., Burton, B. K., Charrow, J. & Rinaldi, J. A.

Shire Human Genetic Therapies, Inc.

6/15/15 → 12/31/19

Project: Research project